Table 2.
Baseline Characteristics of the Deriving Cohort Enrolled in This Study on Admission
| Variables | Total Population (n=120) | Nonsurvivor (n = 38) | Survivor (n =82) | Univariate Logistic Regression | Multivariate Logistic Regression | ||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | P | 0R (95% CI) | P | ||||
| Clinical characteristics | |||||||
| Age (y) | 48.68±13.61 | 54.34±12.78 | 46.05±13.25 | 1.049(1.017–1.082) | 0.003 | 1.068(1.021–1.118) | 0.005 |
| Gender (female/male) | 16/104 | 5/33 | 11/71 | 0.978(0.314–3.042) | 0.969 | ||
| SBP | 38(31.67%) | 14 (36.8%) | 24 (29.3%) | 1.410(0.625–3.178) | 0.408 | ||
| HE (mild/serve) | 5/12 | 4/10 | 1/2 | 15.361(4.071–57.965) | <0.001 | 12.025(1.719–84.105) | 0.009 |
| Laboratory parameters | |||||||
| WBC (×109/L) | 7.11±4.08 | 7.86±4.03 | 6.77±4.08 | 1.065(0.970–1.169) | 0.186 | – | – |
| Neutrophil (×109/L) | 5.11±3.66 | 6.05±3.59 | 4.69±3.63 | 1.102(0.992–1.226) | 0.071 | ||
| Platelet (×109/L) | 86.50(63.25–125.00) | 79.00(50.75–103.00) | 95.00(67.25–139.50) | 0.991(0.983–0.999) | 0.033 | 0.985(0.971–0.999) | 0.039 |
| Total protein (g/L) | 57.82±8.07 | 55.91±7.88 | 58.71±8.04 | 0.957(0.910–1.005) | 0.081 | – | – |
| Albumin (g/L) | 29.62±4.77 | 29.40±3.99 | 29.72±5.11 | 0.986(0.909–1.069) | 0.729 | ||
| Globulin (g/L) | 28.20±7.81 | 26.51±7.01 | 28.99±8.07 | 0.958(0.909–1.009) | 0.108 | ||
| A/G | 1.04(0.84–1.40) | 1.05(0.92–1.43) | 1.01(0.81–1.40) | 1.330(0.619–2.854) | 0.465 | – | – |
| ALT (U/L) | 403.50(130.25–768.25) | 574.00(281.50–940.25) | 349.50(99.50–654.50) | 1.001(1.000–1.002) | 0.027 | – | – |
| AST (U/L) | 263.50(157.00–611.50) | 491.50(239.00–859.50) | 214.00(121.75–424.75) | 1.001(1.000–1.002) | 0.046 | – | – |
| Serum bilirubin (mg/dL) | 19.52±8.23 | 20.47±6.81 | 19.08±8.82 | 1.021(0.974–1.069) | 0.389 | ||
| BUN (mmol/L) | 4.26(3.05–5.65) | 4.35(3.08–6.94) | 4.19(3.02–5.33) | 1.048(0.957–1.147) | 0.311 | ||
| Creatinine (mg/dL) | 0.84(0.70–1.02) | 0.86(0.71–1.15) | 0.81(0.70–1.00) | 2.314(0.888–6.030) | 0.086 | – | |
| INR | 2.17(1.78–2.64) | 2.59(2.06–4.13) | 2.04(1.66–2.39) | 3.117(1.772–5.483) | <0.001 | 2.197(1.005–4.805) | 0.049 |
| Lg (DNA) | 4.93±1.75 | 5.12±1.54 | 4.83±1.84 | 1.120(0.897–1.397) | 0.317 | – | |
| Prealbumin | 34.00(20.00–61.00) | 20.00(12.00–34.50) | 36.00(26.00–67.25) | 0.959(0.937–0.982) | 0.001 | 0.963(0.934–0.994) | 0.018 |
| HIAPP score | −1.63±2.74 | 0.97±0.41 | −2.80±0.21 | <0.001 | |||
| MELD | 25.49±6.78 | 29.78±7.73 | 23.50±5.25 | <0.001 | |||
Note: Data presented as means ± SD or medians (P25‐P75).
Abbreviations: SBP, spontaneous bacterial peritonitis; HE, Hepatic encephalopathy; A/G, albumin/globulin.